Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

被引:1
|
作者
Kikuchi, Taku [1 ,2 ]
Tsukada, Nobuhiro [1 ]
Kunisada, Kodai [1 ]
Yogo, Moe [1 ]
Oda, Yuki [1 ]
Sato, Kota [1 ]
Takei, Tomomi [1 ]
Ogura, Mizuki [1 ]
Abe, Yu [1 ]
Suzuki, Kenshi [1 ]
Ishida, Tadao [1 ]
机构
[1] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
[2] Japanese Red Cross Med Ctr, Dept Hematol, 4 Chome-1-22 Hiroo, Tokyo 1508935, Japan
关键词
MINIMAL RESIDUAL DISEASE; LENALIDOMIDE MAINTENANCE;
D O I
10.1002/hon.3248
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [2] Impact of Revised International Staging System 2 (R2-ISS) Risk Stratification on Outcomes of Patients with Multiple Myeloma Receiving Autologous Hematopoietic Stem Cell Transplantation
    Alzahrani, Kamal
    Pasvolsky, Oren
    Wang, Zhongya
    Milton, Denai R.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer A.
    Saini, Neeraj Y.
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Manasanch, Elisabet E.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BLOOD, 2023, 142
  • [3] Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
    Yan, Wenqiang
    Fan, Huishou
    Xu, Jingyu
    Liu, Jiahui
    Li, Lingna
    Du, Chenxing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    CHINESE MEDICAL JOURNAL, 2023, 136 (14) : 1744 - 1746
  • [4] The second revision of international staging system (R2-ISS) in newly diagnosed multiple myeloma patients: RWE settings
    Sretenovic, Aleksandra
    Mitrovic, Marko
    Vukosavljevic, Nikola
    Kecman, Natalija
    Jovanovic, Jelica
    Bukumiric, Zoran
    Bila, Jelena
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S93 - S93
  • [5] Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
    Yan Wenqiang
    Fan Huishou
    Xu Jingyu
    Liu Jiahui
    Li Lingna
    Du Chenxing
    Deng Shuhui
    Sui Weiwei
    Xu Yan
    Zou Dehui
    Qiu Lugui
    An Gang
    中华医学杂志英文版, 2023, 136 (14)
  • [6] Is the Second Revision of the International Staging System (R2-ISS) for Multiple Myeloma Valid in a Real-World Population from China?
    Yan, Wenqiang
    Li, Lingna
    Fan, Huishou
    Xu, Jingyu
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    BLOOD, 2022, 140 : 7255 - 7256
  • [7] Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice
    Mizuguchi, Makiko
    Okamoto, Yasunobu
    Yagi, Hikaru
    Kagawa, Kumiko
    Sekimoto, Etsuko
    Shibata, Hironobu
    Shigekiyo, Toshio
    Ozaki, Shuji
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (05) : 718 - 728
  • [8] Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
    D'Agostino, Mattia
    Cairns, David A.
    Lahuerta, Juan Jose
    Wester, Ruth
    Bertsch, Uta
    Waage, Anders
    Zamagni, Elena
    Mateos, Maria-Victoria
    Dall'Olio, Daniele
    van de Donk, Niels W. C. J.
    Jackson, Graham
    Rocchi, Serena
    Salwender, Hans
    Creixenti, Joan Blade
    van der Holt, Bronno
    Castellani, Gastone
    Bonello, Francesca
    Capra, Andrea
    Mai, Elias K.
    Durig, Jan
    Gay, Francesca
    Zweegman, Sonja
    Cavo, Michele
    Kaiser, Martin F.
    Goldschmidt, Hartmut
    Hernandez Rivas, Jesus Maria
    Larocca, Alessandra
    Cook, Gordon
    San-Miguel, Jesus F.
    Boccadoro, Mario
    Sonneveld, Pieter
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (29) : 3406 - +
  • [9] Clinical relevance of high-risk cytogenetic abnormalities and the second revision of the International Staging System (R2-ISS) in patients with multiple myeloma in clinical practice
    Makiko Mizuguchi
    Yasunobu Okamoto
    Hikaru Yagi
    Kumiko Kagawa
    Etsuko Sekimoto
    Hironobu Shibata
    Toshio Shigekiyo
    Shuji Ozaki
    International Journal of Hematology, 2023, 117 : 718 - 728
  • [10] Application of R2-ISS risk stratification to patients with multiple myeloma treated with autologous stem cell transplants at UAMS
    Guo, Wancheng
    Zhan, Anne
    Mery, David E.
    Munshi, Manit N.
    Makhoul, Oussama
    Baily, Clyde
    Zangari, Maurizio
    Tricot, Guido
    Peng, Hongling
    Shaughnessy Jr, John D.
    BLOOD ADVANCES, 2023, 7 (21) : 6676 - 6684